Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SU 88

Known as: SU-88 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
  • Theodore J. Criares
  • 2017
  • Corpus ID: 150386396
(52) U.S. Cl. ........................ 514/573; 514/455; 514/458 Prostaglandin 15-Hvdroxvdehvdrogenase Activitv in 9… Expand
Is this relevant?
1987
1987
A study was made on the therapeutic effects of sofalcone (SU-88), an antiulcer agent, on erosive and atrophic gastritis induced… Expand
Is this relevant?
1986
1986
A study was made on changes in the gastric mucosal prostaglandin (PGE2) at the time of onset of stress ulcer in view of the… Expand
Is this relevant?
1985
1985
The biosynthesis of rat gastric glycoproteins with or without sulfate was investigated in rats subjected to restraint and water… Expand
Is this relevant?
1984
1984
SU-88 [2'-carboxymethoxy-4,4'-bis(3-methyl-2-butenyloxy)chalcone] inhibited the activity of the prostaglandin (PG)-metabolizing… Expand
Is this relevant?
1984
1984
2'-Carboxymethoxy-4,4'-bis(3-methyl-2-butenyloxy) chalcone (SU-88) has an anti-ulcer effect which is considered to increase the… Expand
Is this relevant?
1984
1984
The gastric cytoprotective action of SU-88, an anti-ulcer agent, was studied in rats. SU-88 dose-dependently prevented the… Expand
Is this relevant?
1983
1983
Effect of 2'-carboxymethoxy-4,4'-bis(3-methyl-2-butenyloxy)chalcone (SU-88), a new anti-ulcer drug, on gastric tissue blood flow… Expand
Is this relevant?
1982
1982
Effects of a newly synthetized anti-ulcer drug, 2'Carboxymethoxy-4,4'-bis(3-methyl-2-butenloxy)chalcone (SU-88), on gastric blood… Expand
Is this relevant?